To amend the Internal Revenue Code of 1986 to establish a refundable credit for expenses incurred for in vitro fertilization.
Latest Action
Referred to the House Committee on Ways and Means.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™This bill proposes an amendment to the Internal Revenue Code of 1986 to create a refundable tax credit for expenses incurred for in vitro fertilization (IVF). The credit would help individuals or families offset the costs associated with IVF treatments by providing a refundable credit on their federal taxes. The bill was introduced in the House of Representatives during the 118th Congress but lacks a detailed official summary and full text publicly available. As of the latest update, the bill was referred to the House Committee on Ways and Means and has since failed or expired without further legislative action.
The bill aimed to provide financial relief for IVF expenses through a refundable tax credit but did not advance beyond committee referral and is currently expired.
- The bill seeks to amend the Internal Revenue Code to establish a refundable tax credit for IVF-related expenses.
- The refundable credit would reduce the financial burden of IVF treatments for eligible taxpayers.
- The bill was referred to the House Committee on Ways and Means but did not progress and is now classified as failed or expired.
['Individuals and families incurring expenses for in vitro fertilization treatments', 'Taxpayers eligible to claim refundable tax credits', 'Healthcare providers and clinics offering IVF services may see indirect demand effects']
['The bill text and cost estimates are not publicly available, limiting assessment of fiscal impact.', 'Implementation details such as eligibility criteria, credit amount, and administration are unspecified.', 'Oversight mechanisms and enforcement provisions are not described, which may affect program integrity.', 'The refundable nature of the credit could have budgetary implications for federal revenue.']
The bill was introduced in the House during the 118th Congress and referred to the House Committee on Ways and Means, the committee responsible for tax legislation. No further legislative action has been recorded, and the bill is currently marked as failed or expired. The policy area is taxation, focusing on tax credits related to healthcare expenses.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Potential increase in demand for IVF services due to reduced out-of-pocket costs for patients.', 'Possible administrative burden on the IRS to process and verify refundable credits related to medical expenses.', 'Influence on insurance markets or employer-provided health benefits if tax credits alter patient payment dynamics.']
Transparency is limited by the absence of a full bill text and official summary, restricting comprehensive analysis. The bill's referral to the House Committee on Ways and Means aligns with standard procedure for tax-related legislation. The lack of subsequent legislative activity and the bill's expired status indicate no current movement. Oversight considerations include the need for clear eligibility criteria and enforcement mechanisms to prevent misuse of refundable credits.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.